Skip to content

Emily M. Leproust, Chief Executive Officer at Twist Bioscience, sold TWST on Aug 25, 2026

Data as of Oct 16

▼ SELL$1.9M12,236 shares at $151.35Emily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp
Watch TWST
Traded
Aug 25, 2026
Disclosed
Aug 27, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Emily M. Leproust, Chief Executive Officer at Twist Bioscience, sold TWST on Aug 25, 2026TRADEDDISCLOSED
TWSTSimilar stocks (XLV — its sector index fund), rebased to TWST's price on the disclosure day
TWST since disclosure
−13.3%
after the sale
Similar stocks (XLV) since disclosure
+3.0%
XLV — its sector index fund

Change in closing price from Aug 27, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLEmily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp$1.4Mdisclosed Aug 27 · filed 2 days after the trade
  2. ▼ SELLEmily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp$979Kdisclosed Aug 27 · filed 2 days after the trade
  3. ▼ SELLEmily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp$169Kdisclosed Aug 27 · filed 2 days after the trade
  4. ▼ SELLEmily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp$1.9Mdisclosed Aug 27 · filed 2 days after the trade

See every trade on TWST →